Gene therapy resource program (gtrp): pharmacology and toxicology core laboratory
Ended Awarded Last action
- Contract number
- 75N92022F00001
- Awardee
-
Lovelace Biomedical Research Institute UEI MBT9RXJJ7428
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,143,792
Award facts
- Contract value 100% obligated
- $1,143,792.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albuquerque, NM 87108, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$110,621 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,254,413 |
About this award
This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to the Lovelace Biomedical Research Institute. The $1,143,792.16 cost-plus-fixed-fee contract is for the GENE THERAPY RESOURCE PROGRAM (GTRP) and calls for the awardee to provide a Pharmacology and Toxicology Core Laboratory. The contract does not have a set-aside designation. Lovelace Biomedical Research Institute is a not-for-profit preclinical contract research organization that supports various federal agencies like NIH, DoD, and HHS with a range of preclinical research services including animal studies, analytical testing, and product manufacturing. The contract is a Delivery Order issued under a larger contract vehicle, but details about the overarching program were not provided.
Quick answers
Who was awarded contract 75N92022F00001?
75N92022F00001 was awarded to Lovelace Biomedical Research Institute by National Heart Lung and Blood Institute (National Institutes of Health) on September 9, 2022.
How much is contract 75N92022F00001 worth?
The government has obligated $1,143,792 on 75N92022F00001.
Is contract 75N92022F00001 an order under another contract?
Yes. 75N92022F00001 is a delivery order under 75N92019D00017, an indefinite delivery contract.
Was contract 75N92022F00001 competed?
The extent of competition for 75N92022F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award